{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:25:20Z","timestamp":1794003920484,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.jvir.2026.109114","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:07Z","timestamp":1791216487000},"page":"109114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Yttrium-90 Radioembolization for High-Risk Hepatocellular Adenomas: A Single-Institution Experience"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-965X","authenticated-orcid":false,"given":"Nathan","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-8813","authenticated-orcid":false,"given":"Alex","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-8061","authenticated-orcid":false,"given":"Bryan","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenanan","family":"Vairavamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Bishay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-5859","authenticated-orcid":false,"given":"Aaron","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lookstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirema","family":"Garcia-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2026.109114_bib1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","article-title":"ACG clinical guideline: focal liver lesions","volume":"119","author":"Frenette","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2026.109114_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/liv.14074","article-title":"The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: a retrospective cohort study","volume":"39","author":"Haring","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jvir.2026.109114_bib3","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/liv.14547","article-title":"New insights in the management of hepatocellular adenoma","volume":"40","author":"Klompenhouwer","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jvir.2026.109114_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.gassur.2024.03.010","article-title":"Hepatic adenoma: evolution of a more individualized treatment approach","volume":"28","author":"Aziz","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jvir.2026.109114_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2014.05.023","article-title":"Management of hepatocellular adenoma: recent advances","volume":"13","author":"Agrawal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2026.109114_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1245\/s10434-018-6802-1","article-title":"Elective regional therapy treatment for hepatic adenoma","volume":"26","author":"Silva","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2026.109114_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/bjs.10547","article-title":"Systematic review of transarterial embolization for hepatocellular adenomas","volume":"104","author":"van Rosmalen","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvir.2026.109114_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/bjs.11213","article-title":"Safety and efficacy of transarterial embolization of hepatocellular adenomas","volume":"106","author":"van Rosmalen","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvir.2026.109114_bib9","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2026.109114_bib10","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2026.109114_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2026.109114_bib12","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jvir.2025.05.009","article-title":"Histopathologic response and oncologic outcomes after segmental and subsegmental transarterial chemoembolization and radioembolization for hepatocellular carcinoma","volume":"36","author":"Sher","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL Clinical Practice Guidelines on the management of benign liver tumours","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2026.109114_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14157","article-title":"AAPM Medical Physics Practice Guideline 14.a: yttrium-90 microsphere radioembolization","volume":"25","author":"Busse","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.jvir.2026.109114_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jvir.2026.109114_bib16","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2026.109114_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/bjs.9493","article-title":"Risk factors for bleeding in hepatocellular adenoma","volume":"101","author":"Bieze","year":"2014","journal-title":"Br J Surg"},{"key":"10.1016\/j.jvir.2026.109114_bib18","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240333","article-title":"The evolving application of radiation segmentectomy for the treatment of hepatic malignancy","volume":"316","author":"Lewandowski","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2026.109114_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2026.109114_bib20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00270-025-04161-0","article-title":"Comparison of dosimetry models and dose thresholds for predicting pathologic response to yttrium-90 radioembolization with glass microspheres","volume":"48","author":"Pianka","year":"2025","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jvir.2015.12.752","article-title":"Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria","volume":"27","author":"Gaba","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2026.109114_bib24","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/j.jacr.2023.08.023","article-title":"ACR Appropriateness Criteria\u00ae abnormal liver function tests","volume":"20","author":"Arif-Tiwari","year":"2023","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.2012.186","article-title":"Does this patient with liver disease have cirrhosis?","volume":"307","author":"Udell","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jvir.2026.109114_bib26","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.231386","article-title":"Efficacy and safety of radiation segmentectomy with (90)Y resin microspheres for hepatocellular carcinoma","volume":"311","author":"Sarwar","year":"2024","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2026.109114_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00270-023-03391-4","article-title":"Predictive factors for adverse event outcomes after transarterial radioembolization with yttrium-90 resin microspheres in Europe: results from the prospective observational CIRT study","volume":"46","author":"Maleux","year":"2023","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib28","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma","volume":"36","author":"Chow","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2026.109114_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"(90)Y Radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2026.109114_bib30","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jvir.2015.09.021","article-title":"Microwave ablation for the treatment of hepatic adenomas","volume":"27","author":"Smolock","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jvir.2011.02.024","article-title":"Safety and efficacy of radiofrequency ablation for hepatocellular adenoma","volume":"22","author":"van Vledder","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/02656736.2022.2082562","article-title":"Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas","volume":"39","author":"Laimer","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.jvir.2026.109114_bib33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00270-018-1893-4","article-title":"Retrospective single-arm cohort study of patients with hepatocellular adenomas treated with percutaneous thermal ablation","volume":"41","author":"Mironov","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.109114_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1477-2574.2012.00584.x","article-title":"Management of hepatocellular adenoma: comparison of resection, embolization and observation","volume":"15","author":"Karkar","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jvir.2026.109114_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.31559","article-title":"Reproductive health and liver disease: practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Sarkar","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2026.109114_bib36","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2967\/jnumed.107.045443","article-title":"Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres","volume":"48","author":"Gulec","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2026.109114_bib37","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1002\/cncr.26182","article-title":"Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia\/acute myelogenous leukemia","volume":"117","author":"Guidetti","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2026.109114_bib38","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.251923","article-title":"Consortium on Bridging Radiation Segmentectomy (COBRAS): a multicenter study of complete pathologic necrosis in hepatocellular carcinoma","volume":"319","author":"Berman","year":"2026","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2026.109114_bib39","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00259-025-07179-1","article-title":"Achieving complete pathologic necrosis in hepatocellular carcinoma treated with radiation segmentectomy before liver transplantation: a comprehensive glass microsphere analysis","volume":"52","author":"Montazeri","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326011255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044326011255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:01:56Z","timestamp":1794002516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044326011255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S1051044326011255"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2026.109114","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yttrium-90 Radioembolization for High-Risk Hepatocellular Adenomas: A Single-Institution Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2026.109114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2026","name":"copyright","label":"Copyright"}],"article-number":"109114"}}